| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |